Hans Schreiber to Drug Evaluation, Preclinical
This is a "connection" page, showing publications Hans Schreiber has written about Drug Evaluation, Preclinical.
Connection Strength
0.066
-
Cancer immunotherapy and preclinical studies: why we are not wasting our time with animal experiments. Hematol Oncol Clin North Am. 2006 Jun; 20(3):567-84.
Score: 0.066